Pharma Surge

Pharma Surge

đŸŒÂ·3d agoResearch

Dalpiciclib plus endocrine therapy in women with HR + /HER2 − advanced breast cancer and visceral crisis: a multicenter, nonrandomized, phase 2 DARVIN trial

Publisher

N
Nature Cancer

Global

This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.

Read original

At a glance

Publisher
Nature Cancer
Region
Global
Scope
Research
Published
July 21, 2026

In-platform summary, original article off-platform

This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.

Source route

Continue on nature.com

Leave the platform to read the original full article on the publisher site.

Source: Nature Cancer

Scope: Research

Open original article
Dalpiciclib plus endocrine therapy in women with HR + /HER2 − advanced breast cancer and visceral crisis: a multicenter, nonrandomized, phase 2 DARVIN trial | Pharma Surge